+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2026-2032- Product Image
Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2026-2032- Product Image
Sale

Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082253
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioabsorbable Eluting Coronary Stent System Market is projected to reach USD 1.54 Billion in 2026. It is expected to continue growing at a CAGR of 11.58%, reaching USD 2.98 Billion by 2032.

Bioabsorbable-Eluting Coronary Stent Systems: Executive Overview

Bioabsorbable-eluting coronary stent systems combine temporary mechanical support with controlled drug delivery and subsequent material resorption. Their clinical value proposition is to reduce long-term foreign-body presence while maintaining adequate vessel scaffolding during healing. Adoption is shaped by evidence quality, procedural reliability, regulatory requirements, reimbursement, physician familiarity, and patient selection.

Clinical Evidence and Device Design Are Reshaping the Landscape

The field is shifting from novelty-driven development toward evidence-led assessment of long-term outcomes, including restenosis, thrombosis, vessel healing, late lumen behavior, and repeat intervention. Design priorities include thinner struts, predictable degradation, controlled drug release, radial strength, deliverability, and radiographic visibility. Manufacturing consistency and post-market surveillance remain essential because small changes in polymer behavior, coating performance, or deployment characteristics can affect clinical performance.

Artificial Intelligence Is Strengthening Development, Selection, and Monitoring

Artificial intelligence can support nonclinical design optimization, imaging interpretation, lesion characterization, procedural planning, and identification of patients who may benefit from specific device strategies. Machine-learning tools can also assist with signal detection in clinical and post-market data, while generative methods may accelerate material and coating research. Effective deployment requires representative datasets, prospective validation, explainability, cybersecurity, and clear accountability for clinical decisions; AI should augment rather than replace physician judgment.

Regional Insights: Regulation, Infrastructure, and Evidence Determine Adoption

North America emphasizes rigorous clinical evidence, regulatory documentation, reimbursement justification, and advanced interventional infrastructure. Europe combines sophisticated cardiology services with increasingly demanding clinical, safety, and post-market requirements. Asia-Pacific presents substantial procedural diversity, with adoption influenced by local manufacturing capability, hospital purchasing systems, reimbursement, and training capacity. Latin America is shaped by public-private healthcare differences, import dependence, and uneven access to catheterization services. In the Middle East, tertiary-care investment and specialist concentration support adoption, while procurement and reimbursement vary across markets. Africa remains highly heterogeneous, with limited catheterization capacity and affordability acting as central constraints alongside opportunities to strengthen referral networks and specialist training.

Group Insights: Economic and Regulatory Blocs Create Different Operating Conditions

ASEAN markets differ in regulatory maturity, hospital financing, and access to interventional cardiology, making localized registration and distribution strategies important. BRICS economies combine large and diverse patient populations with varying domestic production, reimbursement, and procurement environments. The European Union requires alignment with regional regulatory and evidence expectations while retaining substantial national variation in purchasing and coverage. G7 systems generally place strong emphasis on comparative clinical value, quality systems, and post-market evidence. GCC countries often concentrate advanced cardiac care in major urban and tertiary institutions. NATO members are not a uniform healthcare bloc, but many share high expectations for supply resilience, device security, and sophisticated clinical infrastructure.

Country Insights: National Evidence and Access Conditions Shape Commercial Readiness

Australia and Canada emphasize evidence-based procurement and geographically dispersed care delivery. Brazil and Mexico face marked variation between private and public systems, with reimbursement and import processes influencing availability. China and India combine expanding interventional capacity with significant regional differences and growing interest in local manufacturing and clinical evidence. Japan and South Korea maintain advanced cardiovascular infrastructure and detailed regulatory expectations. France, Germany, Italy, Spain, and the United Kingdom assess devices through distinct national or regional pathways, with hospital procurement, health technology assessment, and post-market obligations affecting uptake. Russia’s operating environment is influenced by regulatory, supply, and healthcare-access conditions. In the United States, adoption depends on regulatory clearance, physician confidence, payer recognition, hospital economics, and robust long-term clinical data.

Actionable Priorities for Leaders in Bioabsorbable Coronary Technologies

Industry leaders should prioritize well-designed comparative studies with meaningful long-term endpoints and transparent subgroup analysis. Device programs should integrate material science, coating control, imaging compatibility, delivery performance, and manufacturing validation from the earliest design stages. Regulatory strategies should be tailored to each jurisdiction, supported by traceable quality systems and active post-market surveillance. Commercial teams should develop physician training, imaging-based case selection, and health-economic evidence rather than relying on technical differentiation alone. Partnerships with hospitals, researchers, and data specialists can improve clinical adoption while responsible AI governance should address validation, bias, privacy, and human oversight.

Research Methodology: Evidence-Led Assessment of a Specialized Device Market

This executive summary uses a structured secondary-research framework focused on the clinical, technical, regulatory, healthcare-delivery, and reimbursement factors relevant to bioabsorbable-eluting coronary stent systems. Analysis should triangulate peer-reviewed studies, clinical-trial records, regulatory publications, professional-society guidance, procurement documentation, and publicly available healthcare data. Findings should be screened for source quality, publication date, geographic relevance, endpoint comparability, and potential conflicts. Because device performance and access conditions vary by indication and jurisdiction, conclusions should distinguish established evidence from emerging hypotheses and should be updated as long-term follow-up becomes available.

Conclusion: Evidence and Execution Will Define Sustainable Adoption

Bioabsorbable-eluting coronary stent systems address an important clinical ambition: providing temporary support and drug delivery without a permanent implant. Their sustainable advancement depends less on novelty than on dependable degradation, procedural usability, durable patient outcomes, credible comparative evidence, and consistent regulatory and manufacturing execution. Leaders that connect engineering discipline with physician education, patient selection, post-market learning, and region-specific access strategies will be better positioned to translate the technology’s potential into responsible clinical use.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioabsorbable Eluting Coronary Stent System Market, by Product Type
7.1. Introduction
7.2. Balloon Expandable
7.3. Self Expandable
8. Bioabsorbable Eluting Coronary Stent System Market, by Drug Type
8.1. Introduction
8.2. Biolimus
8.3. Everolimus
8.4. Sirolimus
9. Bioabsorbable Eluting Coronary Stent System Market, by Polymer Type
9.1. Introduction
9.2. Poly-L-Lactic Acid
9.3. Polycaprolactone
10. Bioabsorbable Eluting Coronary Stent System Market, by Indication
10.1. Introduction
10.2. Acute Coronary Syndrome
10.2.1. Non-ST Elevation Myocardial Infarction
10.2.2. ST Elevation Myocardial Infarction
10.2.3. Unstable Angina
10.3. Stable Angina
11. Bioabsorbable Eluting Coronary Stent System Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Specialty Centers
11.4. Hospitals
12. Bioabsorbable Eluting Coronary Stent System Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Bioabsorbable Eluting Coronary Stent System Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Bioabsorbable Eluting Coronary Stent System Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Amaranth Medical Inc.
16.3. Arterial Remodeling Technologies SA
16.4. B. Braun Melsungen AG
16.5. Biosensors International Group Ltd
16.6. BIOTRONIK SE & Co. KG
16.7. Boston Scientific Corporation
16.8. Elixir Medical Corporation
16.9. Essen Technology Co. Ltd.
16.10. Kyoto Medical Planning Co. Ltd.
16.11. Lepu Medical Technology Co. Ltd.
16.12. Lifetech Scientific Co. Ltd.
16.13. Meril Life Sciences Pvt. Ltd.
16.14. MicroPort Scientific Corporation
16.15. REVA Medical LLC
16.16. Sahajanand Medical Technologies Private Limited
16.17. SINOMED
16.18. Terumo Corporation
16.19. Translumina Therapeutics LLP
16.20. Vascular Concepts Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Bioabsorbable Eluting Coronary Stent System Market, Years Considered for the Study
FIGURE 2. Global Bioabsorbable Eluting Coronary Stent System Market, Research Design
FIGURE 3. Global Bioabsorbable Eluting Coronary Stent System Market, Research Framework
FIGURE 4. Global Bioabsorbable Eluting Coronary Stent System Market, Data Triangulation
FIGURE 5. Global Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 9. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2025 vs 2032 (%)
FIGURE 11. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Bioabsorbable Eluting Coronary Stent System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Bioabsorbable Eluting Coronary Stent System Market Segmentation & Coverage
TABLE 2. Global Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Balloon Expandable Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Balloon Expandable Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Balloon Expandable Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Self Expandable Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Self Expandable Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Self Expandable Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 11. Global Biolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Biolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Biolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Everolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Everolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Everolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Sirolimus Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Sirolimus Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Sirolimus Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 21. Global Poly-L-Lactic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Poly-L-Lactic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Poly-L-Lactic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Polycaprolactone Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Polycaprolactone Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Polycaprolactone Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 28. Global Acute Coronary Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Acute Coronary Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Acute Coronary Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Non-ST Elevation Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Non-ST Elevation Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Non-ST Elevation Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global ST Elevation Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global ST Elevation Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global ST Elevation Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Unstable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Unstable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Unstable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 44. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Cardiac Specialty Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Cardiac Specialty Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Cardiac Specialty Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 64. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 65. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 66. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 67. North America Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 71. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 72. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 73. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 74. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 78. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 79. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 80. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 81. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 85. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 86. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 87. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 88. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 92. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 93. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 94. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 95. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 100. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 101. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 102. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 103. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 107. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 108. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 109. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 110. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 114. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 115. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 116. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 117. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 121. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 122. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 123. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 124. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 128. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 129. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 130. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 131. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 135. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 136. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 137. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 138. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. United States Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 141. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 143. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 144. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 145. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 146. United States Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Canada Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 148. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 150. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 151. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 153. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 155. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 157. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 158. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 160. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 162. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 164. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 165. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 166. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 167. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 169. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 171. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 172. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 173. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 174. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Germany Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 176. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 178. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 179. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 180. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 181. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. France Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 183. France Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. France Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 185. France Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 186. France Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 187. France Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 188. France Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Russia Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 190. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 192. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 193. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 194. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 195. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Italy Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 197. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 199. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 200. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 201. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 202. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Spain Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 204. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 206. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 207. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 208. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 209. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. China Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 211. China Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. China Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 213. China Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 214. China Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. China Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 216. China Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. India Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 218. India Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. India Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 220. India Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 221. India Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 222. India Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 223. India Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Japan Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 225. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 227. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 228. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 229. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 230. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Australia Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 232. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 234. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 235. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 236. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 237. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
TABLE 239. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 241. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 242. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
TABLE 243. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
TABLE 244. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Global Bioabsorbable Eluting Coronary Stent System Market Share, by Key Player, 2025
TABLE 246. Global Bioabsorbable Eluting Coronary Stent System Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Amaranth Medical Inc.
  • Arterial Remodeling Technologies SA
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Essen Technology Co. Ltd.
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • Lifetech Scientific Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • REVA Medical LLC
  • Sahajanand Medical Technologies Private Limited
  • SINOMED
  • Terumo Corporation
  • Translumina Therapeutics LLP
  • Vascular Concepts Limited

Related Topics

Related Reports

Cobalt Chromium Coronary Stent Market - Global Forecast 2026-2032 - Product Image

Cobalt Chromium Coronary Stent Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Coronary Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2026-2034 - Product Image

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • Global
From
Coronary Stents Market - Global Forecast 2026-2032 - Product Image

Coronary Stents Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.